Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs032220723
JPRN-jRCTs032220723
Completed
N/A

Evaluation of clinical characteristics (solute removal characteristics) by different dilution methods of hemodiafilter MFX-W eco series

Okada Kazuyoshi0 sites8 target enrollmentMarch 24, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Kidney Disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Kidney Disease
Sponsor
Okada Kazuyoshi
Enrollment
8
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Okada Kazuyoshi

Eligibility Criteria

Inclusion Criteria

  • •Patients who meet all of the following criteria are eligible for this study.
  • •(1\)Patients who have undergone online HDF for more than 1 month at the time of informed consent
  • •(2\)Patients who can maintain a stable blood flow rate of 280 mL/min
  • •(3\)Patients using a hemodiafilter with a membrane area of 2\.5m2 or more
  • •(4\)Patients whose dialysis time is longer than 4 hours
  • •(5\)Patients who are ambulatory
  • •(6\)Patients who have given written informed consent to participate in this study
  • •(7\)Men and women aged 18 or over and under 85 at the time of obtaining consent

Exclusion Criteria

  • •In consideration of the safety of the study subjects, patients who meet any of the following critria will be excluded from this study.
  • •(1\) Patients who need to take other blood purification therapies such as peritoneal dialysis that may affect the evaluation of research equipment during the research period
  • •(2\) Patients who have a history of acute symptoms such as anaphylactic reactions caused by polyethersulfone membranes or polyvinylpyrrolidone (PVP) in the past
  • •(3\) Patients participating in other clinical studies that may affect the results of this study during the research period
  • •(4\)Those with renal failure due to serious illness.
  • •(5\) Other patients ineligible whom the principal investigator deems to conduct this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Multicentric study on outcome of treatment of osteosarcoma in India, conducted by Indian Musculo Skeletal Oncology Society
CTRI/2023/05/053100Indian Musculo Skeletal Oncology Society (IMSOS)
Completed
N/A
Prognostic prediction of head and neck squamous cell carcinomas with clinico-pathological parameters and Epidermal growth factor receptors expression status
CTRI/2018/05/014222MOHAMMAD AKHEE25
Recruiting
N/A
Evaluation of clinical and functional parameters in patients with Hemophilia aged above 60 yearsD67HemophiliaD66Hereditary factor VIII deficiencyHereditary factor IX deficiency
DRKS00010176Goethe-Universität Frankfurt200
Not Yet Recruiting
N/A
ELECTROLYTE STATE & OUTCOME IN SEVERE COVID-19 DISEASEHealth Condition 1: U071- COVID 19 virus identified
CTRI/2023/06/053513The Dean, GMCHA
Not Yet Recruiting
N/A
Analysis of clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome.ynch syndrome Colorectal tumor
JPRN-UMIN000025142Tokushima University Hospital, Department of Gastroenterology and Oncology20